Zoetis | ZTS - Operating Profit

Stock Price
116.87
Daily Change
0.81 0.70%
Monthly
0.14%
Yearly
-23.85%
Q2 Forecast
114.37

Zoetis reported $835M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
Bayer EUR 1.11B 1.65B Dec/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Dentsply International USD 538M 26M Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Henry Schein USD 186M 12M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Illumina USD 256M 6M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
J&J USD 6.62B 1.03B Mar/2026
Laboratory Of America USD 382M 15.3M Dec/2025
Merck USD 6.24B 318M Dec/2025
Neogen USD -3.3M 2.08M Dec/2025
Pacira USD 3.19M 9.96M Dec/2025
Perrigo USD 84.4M 9M Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Sanofi EUR 1.94B 239M Mar/2026
Sanofi EUR 1.5B 2.29B Dec/2025
Zoetis USD 835M 101M Dec/2025